Clinical Trial Update: Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of acarbose on abnormal glucose regulation in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Impaired Glucose Tolerance

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Aichi Gakuin University | Conditions: Diabetes Mellitus, Impaired Glucose Tolerance | Phase 4 | Status: UNKNOWN